StockData
JOINT Corp logo

JOINT Corp (JYNT) stock

JYNTNasdaqPatent Owners & LessorsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/307% below fair value
$6.65+0.00 (0.00%)

Close on Nov 18, 2026Market cap $94.05MP/E 33.3Yield –

Earnings

Joint's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 11, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$13.60M
+1.5% on a year earlier
EPS, Q3 FY2026
-$0.01
$0.06 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Joint's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 11, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$13.60M+1.5%-$0.01Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$15.20M+14.3%$0.05Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close$14.80M+13.0%$0.09Release
Q4 FY2025ended Dec 31, 2025Mar 12, 2026after the close$15.20M+5.6%$0.07Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$13.40M-55.6%$0.06Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close$13.30M-56.1%$0.01Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close$13.10M-55.9%$0.05Release
Q4 FY2024ended Dec 31, 2024Mar 13, 2025after the close$14.40M-52.9%$0.06Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024after the close$30.20M+2.4%-$0.21Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close$30.30M–-$0.24Release
Q1 FY2024ended Mar 31, 2024May 2, 2024after the close$29.70M+4.2%$0.06Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Joint's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
System-wide salesFY2026$519.00M – $552.00M$519.00M – $552.00MReaffirmedAug 6, 2026
System-wide comp sales for clinics open 13 months or moreFY2026-3.5% – -2.5%–NewNov 5, 2026
System-wide comp sales for clinics open 13 months or moreFY2026-3% – +3%-3% – +3%ReaffirmedAug 6, 2026
Consolidated Adjusted EBITDAnon-GAAPFY2026$12.50M – $13.50M–NewNov 5, 2026
Consolidated Adjusted EBITDAnon-GAAPFY2026$12.50M – $13.50M$12.50M – $13.50MReaffirmedAug 6, 2026
New franchised clinic openings, excluding the impact of refranchised clinicsFY202622 – 2630 – 35LoweredAug 6, 2026
System-wide salesFY2026$508.00M – $512.00M–NewNov 5, 2026

Guidance history

Every forecast Joint put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026System-wide comp sales for clinics open 13 months or moreFY2026-3.5% – -2.5%New
Nov 5, 2026Consolidated Adjusted EBITDAFY2026$12.50M – $13.50MNew
Nov 5, 2026System-wide salesFY2026$508.00M – $512.00MNew
Aug 6, 2026System-wide comp sales for clinics open 13 months or moreFY2026-3% – +3%Reaffirmed
Aug 6, 2026Consolidated Adjusted EBITDAFY2026$12.50M – $13.50MReaffirmed
Aug 6, 2026New franchised clinic openings, excluding the impact of refranchised clinicsFY202622 – 26Lowered
Aug 6, 2026System-wide salesFY2026$519.00M – $552.00MReaffirmed
May 7, 2026System-wide comp sales for clinics open 13 months or moreFY2026-3% – +3%Reaffirmed
May 7, 2026Consolidated Adjusted EBITDAFY2026$12.50M – $13.50MReaffirmed
May 7, 2026New franchised clinic openings, excluding the impact of refranchised clinicsFY202630 – 35Reaffirmed
May 7, 2026System-wide salesFY2026$519.00M – $552.00MReaffirmed
Mar 12, 2026System-wide comp sales for clinics open 13 months or moreFY2026-3% – +3%New
Mar 12, 2026Consolidated Adjusted EBITDAFY2026$12.50M – $13.50MNew
Mar 12, 2026New franchised clinic openings, excluding the impact of refranchised clinicsFY202630 – 35New
Mar 12, 2026System-wide salesFY2026$519.00M – $552.00MNew
Nov 6, 2025Comp salesFY2025-1% – 0%New
Nov 6, 2025Consolidated Adjusted EBITDAFY2025$10.80M – $11.80MNew
Nov 6, 2025New clinic openingsFY202530 – 35New
Nov 6, 2025System-wide salesFY2025$530.00M – $534.00MNew
Aug 7, 2025Consolidated Adjusted EBITDAFY2025$10.80M – $11.80MRaised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Joint filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. News
  8. Results
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?